Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:29 AM
Ignite Modification Date:
2025-12-25 @ 4:29 AM
NCT ID:
NCT06224920
Eligibility Criteria:
Inclusion Criteria:
* Informed consent for the additional examinations, written declaration of consent
* Constant pharmacotherapy in a period of one week before the MRI/EEG/PET examination
Exclusion Criteria:
* Existence of legal guardianship/restricted capacity to consent
* Other severe concomitant psychiatric illnesses, e.g. schizophrenia, bipolar affective disorder
* Clinically relevant depressive symptoms (Beck Depression Inventory, BDI, score \> 17/GDS \> 5)
* Acute suicidal tendencies
* Drug, medication or alcohol abuse at the time of the study
* Severe traumatic brain injury (\> 2nd degree TBI) in the medical history or 1st degree within the last 3 months.
* Evidence of structural damage to the basal ganglia or brainstem
* Severe neurological diseases (such as disc prolapse in the last 6 months, sensory, motor or autonomic polyneuropathies)
* Severe internal diseases (such as manifest arterial hypertension, severe heart disease, pacemaker, respiratory insufficiency)
* Any electronic implants (e.g. pacemakers) or other MRI and/or PET contraindications
* Malignant diseases of any kind in the last 5 years, severe active infectious diseases, chronic and systemic skin diseases
* Bone diseases (such as Paget's disease, osteoporosis with spontaneous fractures, recent fractures)
* Other circumstances which, in the opinion of the investigator, speak against the patient's participation in this study
* Occupational or other radiation exposure \>15 mSv/a
Sex:
ALL
Minimum Age:
55 Years
Maximum Age:
80 Years
Study:
NCT06224920
Study Brief:
Protocol Section:
NCT06224920